Skip to main content Skip to section navigation Skip to footer

Mydecine Innovations Group Inc.

  • Home
  • About
    • Overview
    • Company History
    • Acquisitions
    • Partnerships
    • Leadership Team
    • Board of Directors
    • Research & Development Team
    • Medical, Scientific and Technology Advisory Board
  • Our Approach
    • IP & Drug Development
    • Clinical Trials
    • Technology
  • Drug Supply
    • Investigational Drug Supply
    • Special Access Program
  • News & Media
    • Blog
    • Press Releases
    • In The News
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • Governance
    • FAQs
  • Contact
  • Careers
  • Search

In The News

News & Media

News & Media

  • Blog
  • Press Releases
  • In The News
Dec 28, 2021

Traditional Doctors See Future In Psychedelics | Mydecine

Dec 28, 2021

Mydecine Advisor Discusses Psychedelics & His Personal Path To Recovery

Dec 24, 2021

Mydecine 2022 Predictions: “Scaling revolves around three things…”

Dec 22, 2021

A Look Back On A Big Year for Mydecine Innovations Group

Dec 22, 2021

Mydecine Agrees To LOI With Maya For Development Of Novel Prescription Platform

Dec 20, 2021

Company Update: A Look at Mydecine Innovations Group

Dec 15, 2021

6 Of The Biggest Psychedelic News Stories of 2021

Dec 13, 2021

Mydecine Innovations talks through recent psilocin analogs, nanoemulsion tech patent applications

Dec 12, 2021

PTSF88 – Dr. Ben Sessa of Awakn Life Sciences + Josh Bartch of Mydecine Innovations Group

Dec 6, 2021

Mydecine Files Full Patent Application Covering Multiple Families of Psilocin Analogs

rss_feed RSS
  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • arrow_forward

Sign up for our Newsletter!

twitter Linkedin Instagram
©2022 Mydecine Innovations Group Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap